Bibliografía
1. Hirano I, Pandolfino JE, Boeckxstaens GE. Functional Lumen Imaging Probe for the Management of Esophageal Disorders: Expert Review From the Clinical Practice Updates Committee of the AGA Institute. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017;15(3):325-34.
2. Carlson DA, Kou W, Lin Z, et al. Normal Values of Esophageal Distensibility and Distension-Induced Contractility Measured by Functional Luminal Imaging Probe Panometry. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019;17(4):674-81.e1.
3. Carlson DA, Lin Z, Hirano I, et al. Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2016;28(12):1844-53.
4. Carlson DA, Lin Z, Rogers MC, et al. Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2015;27(7):981-9.
5. Hirano I, Sharaf R, Stollman N, et al. Spotlight: Treatment of Eosinophilic Esophagitis (EoE). Gastroenterology. 2020;158(6):1788.
6. Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology. 2020;158(4):840-51.
7. Arias A, Lucendo AJ. Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2019;51(1):55-62.
8. de Rooij WE, Barendsen ME, Warners MJ, et al. Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register-based pathology cohort. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2021:e14072.
9. Navarro P, Laserna-Mendieta EJ, Casabona S, et al. Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry. United European gastroenterology journal. 2022;10(5):507-17.
10. Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, et al. The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort. The American journal of gastroenterology. 2018;113(6):836-44.
11. Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230-6.e1-2.
12. Laserna-Mendieta EJ, Navarro P, Casabona-Francés S, et al. Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2022.
13. Lucendo AJ, Molina-Infante J, Arias A, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European gastroenterology journal. 2017;5(3):335-58.
14. Martín Martín L, Santander C, Lopez Martín MC, et al. Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry. Journal of gastroenterology and hepatology. 2011;26(9):1447-50.
15. Molina-Infante J, Arias Á, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. The Journal of allergy and clinical immunology. 2018;141(4):1365-72.
16. Navarro P, Laserna-Mendieta EJ, Guagnozzi D, et al. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2021;53(11):1479-85.
17. Laserna-Mendieta EJ, Casabona S, Guagnozzi D, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Alimentary pharmacology & therapeutics. 2020;52(5):798-807.
18. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526-37, 37.e1.
19. Lucendo AJ, Sanchez-Cazalilla M, Molina-Infante J, et al. Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2014;106(6):386-94.
20. Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489-95.
21. Nicodeme F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013;11(9):1101-7.e1.
22. Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82-90.
23. Carlson DA, Hirano I, Zalewski A, et al. Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis. Clinical and translational gastroenterology. 2017;8(10):e119.
24. Lin Z, Kahrilas PJ, Xiao Y, et al. Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis. Therapeutic advances in gastroenterology. 2013;6(2):97-107.
25. Desprez C, Roman S. The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP(®) ) in the gastrointestinal tract: A systematic review. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2020;32(9):e13980.
26. Hill DA, Grundmeier RW, Ramos M, et al. Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March. The journal of allergy and clinical immunology In practice. 2018;6(5):1528-33.
27. Dellon ES, Woosley JT, Arrington A, et al. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019;157(1):65-73.e5.
28. Miehlke S, Hruz P, Vieth M, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65(3):390-9.
29. Straumann A, Conus S, Degen L, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2011;9(5):400-9.e1.
30. Desprez C, Roman S. The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP(®) ) in the gastrointestinal tract: A systematic review. 2020;32(9):e13980.
31. Smeets FG, Masclee AA, Keszthelyi D, et al. Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2015;27(10):1495-503.
32. Menard-Katcher C, Benitez AJ, Pan Z, et al. Influence of Age and Eosinophilic Esophagitis on Esophageal Distensibility in a Pediatric Cohort. The American journal of gastroenterology. 2017;112(9):1466-73.
33. Kuchen T, Straumann A, Safroneeva E, et al. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. Allergy. 2014;69(9):1248-54.
34. Hirano I, Spechler S, Furuta G, et al. White Paper AGA: Drug Development for Eosinophilic Esophagitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017;15(8):1173-83.
35. Carlson DA, Kou W, Pandolfino JE. The rhythm and rate of distension-induced esophageal contractility: A physiomarker of esophageal function. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2020;32(5):e13794.
Artículos relacionados
Imagen en Patología Digestiva
Esófago negro
DOI: 10.17235/reed.2022.9217/2022